首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1589196篇
  免费   131817篇
  国内免费   2506篇
耳鼻咽喉   21595篇
儿科学   52729篇
妇产科学   46089篇
基础医学   225722篇
口腔科学   47111篇
临床医学   139368篇
内科学   311065篇
皮肤病学   34036篇
神经病学   129182篇
特种医学   64619篇
外国民族医学   474篇
外科学   243032篇
综合类   39629篇
一般理论   546篇
预防医学   121736篇
眼科学   36254篇
药学   120839篇
  2篇
中国医学   2882篇
肿瘤学   86609篇
  2018年   14547篇
  2016年   12754篇
  2015年   14885篇
  2014年   20580篇
  2013年   31292篇
  2012年   42521篇
  2011年   44740篇
  2010年   26291篇
  2009年   25263篇
  2008年   42972篇
  2007年   45209篇
  2006年   46009篇
  2005年   44639篇
  2004年   44062篇
  2003年   42097篇
  2002年   41229篇
  2001年   75585篇
  2000年   78138篇
  1999年   65979篇
  1998年   16707篇
  1997年   15332篇
  1996年   15286篇
  1995年   15943篇
  1994年   14984篇
  1993年   14148篇
  1992年   55370篇
  1991年   53760篇
  1990年   52535篇
  1989年   50799篇
  1988年   47184篇
  1987年   46537篇
  1986年   44259篇
  1985年   42827篇
  1984年   31989篇
  1983年   27519篇
  1982年   16085篇
  1981年   14375篇
  1980年   13491篇
  1979年   30414篇
  1978年   21018篇
  1977年   17688篇
  1976年   16616篇
  1975年   17492篇
  1974年   21411篇
  1973年   20617篇
  1972年   18808篇
  1971年   17723篇
  1970年   16254篇
  1969年   15232篇
  1968年   13924篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty.  相似文献   
3.
Pharmaceutical Chemistry Journal - Metformin hydrochloride is widely used to treat diabetes mellitus. This review presents its physical and chemical properties and discusses methods of analysis...  相似文献   
4.
Khadka  J.  Ratcliffe  J.  Hutchinson  C.  Cleland  J.  Mulhern  B.  Lancsar  E.  Milte  R. 《Quality of life research》2022,31(9):2849-2865
Quality of Life Research - To evaluate the construct (convergent and known group) validity of the Quality-of-Life-Aged Care Consumer (QOL-ACC), an older-person-specific quality-of-life measure...  相似文献   
5.
6.
7.
8.
9.
PurposeTRAPPC9 deficiency is an autosomal recessive disorder mainly associated with intellectual disability (ID), microcephaly, and obesity. Previously, TRAPPC9 deficiency has not been associated with biochemical abnormalities.MethodsExome sequencing was performed in 3 individuals with ID and dysmorphic features. N-Glycosylation analyses were performed in the patients’ blood samples to test for possible congenital disorder of glycosylation (CDG). TRAPPC9 gene, TRAPPC9 protein expression, and N-glycosylation markers were assessed in patient fibroblasts. Complementation with wild-type TRAPPC9 and immunofluorescence studies to assess TRAPPC9 expression and localization were performed. The metabolic consequences of TRAPPC9 deficiency were evaluated using tracer metabolomics.ResultsAll 3 patients carried biallelic missense variants in TRAPPC9 and presented with an N-glycosylation defect in blood, consistent with CDG type I. Extensive investigations in patient fibroblasts corroborated TRAPPC9 deficiency and an N-glycosylation defect. Tracer metabolomics revealed global metabolic changes with several affected glycosylation-related metabolites.ConclusionWe identified 3 TRAPPC9 deficient patients presenting with ID, dysmorphic features, and abnormal glycosylation. On the basis of our findings, we propose that TRAPPC9 deficiency could lead to a CDG (TRAPPC9-CDG). The finding of abnormal glycosylation in these patients is highly relevant for diagnosis, further elucidation of the pathophysiology, and management of the disease.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号